Aggarwal, R., Alumkal, J. J., Szmulewitz, R. Z., Higano, C. S., Bryce, A. H., Lopez-Gitlitz, A., . . . Small, E. J. Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer. Wiley.
Chicago Style (17th ed.) CitationAggarwal, Rahul, et al. Randomized, Open-Label Phase 2 Study of Apalutamide Plus Androgen Deprivation Therapy Versus Apalutamide Monotherapy Versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer. Wiley.
MLA (9th ed.) CitationAggarwal, Rahul, et al. Randomized, Open-Label Phase 2 Study of Apalutamide Plus Androgen Deprivation Therapy Versus Apalutamide Monotherapy Versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer. Wiley.